The Charles T. Campbell Eye Microbiology Lab
UPMC | University of Pittsburgh Medical CenterUniversity of Pittsburgh Schools of the Health Sciences
HomeAbout UsLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchContact Us


Ocular Microbiology and Immunology Group
Back to OMIG Main Page

2006 Abstracts and Meeting Agenda


40th Annual Meeting
Caesars Palace Hotel
Las Vegas, Nevada
Nov. 10, 2006


MODERATORS: Richard K. Forster, MD
James Chodosh, MD

6:45 a.m. Registration

7:30 a.m.The Incidence and Pathogenicity of Propionibacterium Acnes Keratitis at the New York Eye & Ear Infirmary.
B Ovodenko, JA Seedor, MK Shah, DC Ritterband, RS Koplin
The New York Eye and Ear Infirmary, Department of Ophthalmology and Laboratory Medicine

7:38 a.m.Steroid for Corneal Ulcers Trial –Pilot Study Results.
N Acharya1, M Srinivasan2, M Mahalakshmi2, P Lalitha2, S Costanza1, S McLeod1, J Whichter1, M Zegans3, T Lietman1
1Proctor Foundation/UCSF, San Francisco, CA, 2Aravind Eye Hospital,Madurai, India, 3Dartmouth-Hitchcock Medical Center, Dartmouth, NH

7:46 a.m. The in vitro Activity of Three Novel Biomimetics (PMX30006, PMX30016, PMX70004) Against Clinically Relevant Ocular Pathogens.
EG Romanowski, RP Kowalski, FS Mah, YJ Gordon
The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, University of Pittsburgh, Pittsburgh, PA

7:54 a.m. Does Cefuroxime Provide Better in vitro Susceptibility than the 4th Generation Fluoroquinolones and Cefazolin?
JE Contreras, RP Kowalski, FS Mah, PP Thompson
The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, University of Pittsburgh, Pittsburgh, PA

8:02 a.m. Spectrum of Ocular Disease Caused by Methicillin-Resistant Staphylococcus aureus.
J Freidlin, N Acharya, TM Lietman, V Cevallos, JP Whitcher, TP Margolis
Francis I. Proctor Foundation, San Francisco, CA

8:10 a.m. Visualization of the Effect of Moxifloxacin on Pseudomonas aeruginosa.
RMQ Shanks, RP Kowalski, EG Romanowski, FS Mah, YJ Gordon
The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, University of Pittsburgh, Pittsburgh, PA

8:18 a.m.In vitro Activity of CSA-13 (Cationic Steroid Antibiotic) Against Ocular Clinical Isolates.
MK Shah, DC Ritterband, JA Seedor, RS Koplin
The New York Eye and Ear Infirmary and New York Medical College, Department of Ophthalmology and Laboratory Medicine, Valhalla, NY

8:26 a.m. Which Antibiotic is More Consumer Friendly? The Relationship of in vitro Coverage to Cost of Antibiotics.
P Farhi, R Kowalski, F Mah
University of Pittsburgh Medical Center, Pittsburgh, PA

8:34 a.m.Biofilm Forming Capability of Ocular Isolates of Coagulase Negative Staphylococci and Effect of Biofilm Inhibitors.
S Sharma, A Duggirala, TP Das, P Garg, B Dorairajan
L.V. Prasad Eye Institute, Hyderabad India

8:42 a.m. A Common Additive to Eye Drops, Polysorbate 80, Inhibits Biofilm Formation of Pseudomonas aeruginosa.
CM Toutain1, CT Bramante2, ME Zegans1
1Dartmouth Medical School, 2Dartmouth College

8:50 a.m. Repeated Mass Antibiotic Treatments for Infectious Trachoma in a Hyperendemic Area: Elimination is Feasible.
BD Gaynor1,2, M Melese3, W Alemayehu3, T Lakew3, JD Chidambaram1, J House1, KC Hong1, K Maxey1, JP Whitcher1,2, TM Lietman1,2
1F.I. Proctor Foundation and the 2Department of Ophthalmology, University of California, San Francisco, USA. 3Orbis International, Ethiopia

8:58 a.m. In vitro Synergy of Emerging Antimicrobial Agents against Fusarium spp Isolated from Keratitis in South India.
B Shapiro1, P Lalitha2, M Srinivasan2, NV Prajna2, N Acharya1, A Fothergill3, J Ruiz3, J Chidambaram1, K Maxey1, K Hong1, S McLeod1, T Lietman1
1University of Californnia San Francisco, 2Aravind Eye Hospital, Madurai, India, 3University of Texas Heath Sciences Center San Antonio

9:06 a.m. ReNu-Associated Fusarium Keratitis Outbreak in San Francisco.
JI Ou1,2, MD Bernal1,2, N Acharya1, TM Lietman1, EC Strauss1, SD McLeod1, V Cevallos1, C Donnellan1, DG Hwang1,2
1Francis I. Proctor Foundation and 2Cornea Service, University of California San Francisco (UCSF). San Francisco, CA

9:14 a.m. Clinical Response of Contact Lens Associated Fungal Keratitis on Topical Fluoroquinolone Therapy.
WM Munir1, SI Rosenfeld2, I Udell3, D Miller2, CL Karp2, EC Alfonso2
1Department of Ophthalmology, Boston University School of Medicine, 2Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, 3Department of Ophthalmology, North Shore LIJ Health System, Albert Einstein College of Medicine

9:22 a.m. An Analysis of the Fusarium Keratitis at the New York Eye & Ear Infirmary.
K Chiu, JA Seedor, MK Shah, N Harizman, RS Koplin, DC Ritterband
Department of Ophthalmology and Laboratory Medicine, The New York Eye and Ear Infirmary, New York, NY and New York Medical College, Valhalla, NY

9:30 a.m. Bacterial Proliferation in Acute Pseudophakic Endophthalmitis.
S Kobayakawa1, Y Okajima1, A Tuji2, T Tochikubo1
1Department of Ophthalmology, Toho U., Toyko, Japan, 2Department of infection control and prevention, School of Nursing, Faculty of Medicine, Toho U., Toyko, Japan

9:38 a.m. Moxifloxacin (Vigamox) Prophylaxis Prevents Endophthalmitis in a Rabbit Model Using a Contaminated Intravitreal Injection of Triamcinolone.
RP Kowalski, EG Romanowski, FS Mah, KA Yates, YJ Gordon
The Charles T. Campbell Laboratory, University of Pittsburgh, Pittsburgh, PA.

9:46 a.m. Perspectives on Cefuroxime and the Recent ESCRS Postoperative Endophthalmitis (POE) Study.
TP O'Brien1, SA Arshinoff2, FS Mah3
1Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens, FL, 2University of Toronto, Toronto, Cananda, 3Department of Ophthalmology, University of Pittsburgh, Pittsburgh, PA

9:54 a.m. Therapeutic Keratoplasty for Recurring Infectious Keratitis Following Postoperative Endophthalmitis.
HP Wadia, LA Wiley, J Sugar, MA Joseph
WVU Eye Institute and Illinois Eye & Ear Infirmary

10:02 a.m.Recurrence Rates of Herpes Simplex Virus Keratitis in Contact lens Wearers Compared to Non-Contact Lens Wearers.
JJ Mucci, VA Miraldi, A Galor, BH Jeng
Cole Eye Institute, Cleveland Clinic

10:10 a.m. Clinical Spectrum of Chronic Active Herpes Zoster Keratitis.
MF Chan1, EC Strauss1, A Hu2, GN Holland2, TP Margolis1
1Francis I. Proctor Foundation and Department of Ophthalmology, University of California at San Francisco and 2Jules Stein Eye Institute, Department of Ophthalmology, University of California Los Angeles

10:18 a.m. Characterization of Cytokine Proteomics in Pediatric Subperiosteal Abscesses of the Orbit.
SY Fu, GY Su, SH McKinley, MT Yen
Cullen Eye Institute, Baylor College of Medicine, Houston, TX

10:26 a.m. Benzalkonium Chloride (BAK) Significantly Enhances the Antibacterial Efficacy of Gatifloxacin in the Staphylococcus aureus NZW Rabbit Keratitis Model.
FS Mah, EG Romanowski, RP Kowalski, KA Yates, YJ Gordon
The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, University of Pittsburgh, Pittsburgh, PA

10:34 a.m. Analysis of OMIG Abstracts from 1983-2004: Have the Types of Research Presentations Changed Over Time?
SK Kim, DG Hwang
Francis I. Proctor Foundation and Cornea Service, University of California San Francisco, San Francisco, CA

10:42 a.m. Thygeson LectureWilliam T. Driebe, Jr., MDContact Lens Related Ulcerative Keratitis

11:07 a.m. Closing Comments and Awards

11:15 a.m. Adjourn



Top of Page


Website Terms of Use | E-mail Terms of Use | Medical Advice Disclaimer | UPMC
Affiliated with the University of Pittsburgh Schools of the Health Sciences | Contact UPMC